4 ms·
The paper is available [1]. They did a reasonable job - 9% black/african-american and nearly 30% latino (the trial was run in Argentina and Brazil). Subgroup
by dm319 6y ago
The paper is available [1]. They did a reasonable job - 9% black/african-american and nearly 30% latino (the trial was run in Argentina and Brazil). Subgroup analysis similar efficacy between groups. Around 25% were more than 65. Maybe not so ideal as that is one of the key groups. Immunocompromised were excluded, which is understandable, but the data would have been interesting.
[1] https://www.nejm.org/doi/full/10.1056/NEJMoa2034577?query=RP https://www.nejm.org/doi/full/10.1056/NEJMoa2034577?query=RP
- baud147258 6y ago> the trial was run in Argentina and Brazil why not run the trial in the country where the vaccine is going to be sold?
- dm319 6y agoTo keep your market larger? /s Most trials were run in countries where a large number of new cases were expected over the trial period. Government measures in almost all first world countries brought the R rate right down, which is disastrous for a trial looking for results.
- Rapzid 6y agoBrazil just committed to purchasing 70 million doses..